AXIM BIOTECHNOLOGIES, INC. Quarterly Entity Common Stock, Shares Outstanding from Q4 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Axim Biotechnologies, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2011 to Q3 2024.
  • Axim Biotechnologies, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 16, 2024 was 302M shares, a 27.1% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 302M +64.3M +27.1% Aug 16, 2024 10-Q 2024-08-19
Q2 2024 291M +63.8M +28% May 20, 2024 10-Q/A 2024-05-22
Q1 2024 278M +54.8M +24.5% Apr 13, 2024 10-K 2024-04-16
Q3 2023 238M +51.2M +27.5% Oct 17, 2023 10-Q 2023-11-20
Q2 2023 228M +73.4M +47.6% May 22, 2023 10-Q 2023-05-22
Q1 2023 224M +71.6M +47.1% Apr 14, 2023 10-K 2023-04-17
Q3 2022 186M +53.2M +39.9% Nov 14, 2022 10-Q/A 2022-11-15
Q2 2022 154M +25.4M +19.7% May 20, 2022 10-Q 2022-05-23
Q1 2022 152M +23.1M +18% Apr 12, 2022 10-K/A 2022-04-19
Q4 2021 136M +11M +8.77% Nov 19, 2021 10-Q 2021-11-22
Q3 2021 133M Aug 20, 2021 10-Q 2021-08-23
Q2 2021 129M -2.23M -1.7% May 24, 2021 10-Q/A 2021-06-02
Q1 2021 129M +421K +0.33% Apr 13, 2021 10-K/A 2021-04-26
Q4 2020 125M Nov 18, 2020 10-Q/A 2020-11-27
Q2 2020 131M +68.6M +110% Jun 29, 2020 10-Q/A 2020-07-02
Q1 2020 128M +67.4M +110% May 14, 2020 10-K/A 2020-05-20
Q3 2019 63M +3.85M +6.51% Nov 14, 2019 10-Q 2019-11-14
Q2 2019 62.5M +4.45M +7.67% Aug 12, 2019 10-Q 2019-08-14
Q1 2019 61.1M +5.55M +10% Apr 8, 2019 10-K 2019-04-08
Q3 2018 59.2M +4.62M +8.46% Nov 9, 2018 10-Q 2018-11-14
Q2 2018 58.1M +5.51M +10.5% Aug 10, 2018 10-Q/A 2018-08-17
Q1 2018 55.5M +2.95M +5.61% Mar 14, 2018 10-K 2018-03-15
Q3 2017 54.6M +7.76M +16.6% Nov 14, 2017 10-Q 2017-11-20
Q2 2017 52.6M +12.8M +32.2% May 19, 2017 10-Q/A 2017-09-14
Q1 2017 52.6M +12.8M +32.2% Mar 29, 2017 10-Q/A 2017-09-14
Q4 2016 51.5M +12M +30.4% Nov 21, 2016 10-Q/A 2016-11-30
Q3 2016 46.8M +7.44M +18.9% Aug 20, 2016 10-Q/A 2016-08-25
Q2 2016 39.8M May 23, 2016 10-Q/A 2016-05-26
Q1 2016 39.8M +5.74M +16.9% Apr 13, 2016 10-K/A 2016-04-18
Q4 2015 39.5M Nov 16, 2015 10-Q 2015-11-23
Q3 2015 39.4M +6.36M +19.3% Aug 19, 2015 10-Q/A 2015-08-27
Q1 2015 34M +1.02M +3.09% Apr 9, 2015 10-K 2015-04-14
Q3 2014 33M Oct 30, 2014 10-Q 2014-11-14
Q2 2014 33M 0 0% Aug 14, 2014 10-Q/A 2014-08-26
Q1 2014 33M 0 0% Apr 30, 2014 10-Q/A 2014-06-18
Q4 2013 33M Nov 18, 2013 10-Q 2013-11-18
Q2 2013 33M 0 0% Aug 13, 2013 10-Q 2013-08-14
Q1 2013 33M 0 0% Apr 15, 2013 10-K 2013-04-15
Q2 2012 33M Jun 30, 2012 10-Q 2012-11-19
Q1 2012 33M Apr 16, 2012 10-K/A 2012-05-01
Q4 2011 33M Nov 15, 2011 10-Q/A 2011-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.